Investigational Drugs for the COVID 19 Pandemic – A Concise Review

Favipiravir Pandemic Hydroxychloroquine Ritonavir Tocilizumab Lopinavir
DOI: 10.34172/ps.2020.80 Publication Date: 2020-12-20T07:27:30Z
ABSTRACT
The present year saw the emergence of a pandemic Corona Virus Disease 2019 (COVID 19). unpreparedness for and lack drugs/vaccine against this virus has led to high mortality rate across world. In process, number drugs have been tried corona including antivirals like remdesivir, lopinavir-ritonavir, favipiravir, monoclonal antibodies tocilizumab sarilumab antimalarial chloroquine hydroxychloroquine. At time, none these reported efficacy virus. Here we review all drugs, their proposed mechanism action status in clinical trials.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (117)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....